Jan 18, 2022 11:45AM

Sep 22, 2021 11:45AM

Jun 24, 2021 11:45AM

May 27, 2021 02:41AM

May 27, 2021 02:30AM

Mar 10, 2021 11:45AM

Mar 10, 2021 11:45AM Transgene Expands Phase II Clinical Trial of Therapeutic Vaccine TG4001 in Combination With Avelumab Versus Avelumab Monotherapy in Patients With HPV16-positive Anogenital Cancers

Dec 3, 2020 12:45PM

Nov 9, 2020 11:45AM

Oct 27, 2020 02:30AM

Oct 19, 2020 01:30AM

Jul 22, 2020 10:51AM

Nov 14, 2019 11:45AM

Sep 30, 2019 11:45AM Transgene Reports First Promising Efficacy Results with TG4001 in Combination with Avelumab in HPV-Positive Cancer at ESMO 2019

Sep 16, 2019 11:45AM

Jul 10, 2019 11:46AM

May 13, 2019 11:45AM

May 13, 2019 01:30AM

Dec 20, 2018 11:45AM

Oct 19, 2017 12:00PM

Sep 19, 2017 11:45AM Transgene: First Patient Treated in a Phase 1b/2 Trial of TG4001 in Combination with Avelumab in HPV-Positive Cancers

Sep 19, 2017 11:45AM

Sep 13, 2017 11:35AM

Sep 11, 2017 11:45AM

Apr 25, 2017 01:30AM

Apr 25, 2017 01:30AM

Apr 24, 2017 11:45AM

Apr 24, 2017 11:45AM SillaJen And Transgene Announce the Enrollment of the First European Patient in Multinational Phase 3 Trial For Pexa-Vec in Advanced Liver Cancer

323,584 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All